Skip to main content
SpringerLink
Log in

An Overview of the Role of Calcium Antagonists in the Treatment of Achalasia and Diffuse Oesophageal Spasm

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Early studies confirmed the beneficial effects of calcium channel blockers on the normal oesophagus, which included a decrease in lower oesophageal sphincter tone in achalasia and a decrease in oesophageal contractions and amplitude in diffuse oesophageal spasm. This resulted in the enthusiastic use of the drugs in both disorders. With further experience, and with increased recognition of side effects, the role of these drugs in the 2 disorders has been better clarified. Clinical trials in general have not reflected the improvement observed in the manometric parameters. Only a minority of patients appear to derive sustained symptomatic benefit. Calcium channel blockers may be the initial choice for high or moderate risk patients with achalasia prior to proceeding with pneumatic dilatation or surgical myotomy. In diffuse oesophageal spasm, they are a reasonable first choice for all risk categories.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Adelstein Rs, Eisenberg E. Regulation and kinetics of the actin-myosin-ATP interaction. Annual Review of Biochemistry 49: 921–956, 1980

    Article  PubMed  CAS  Google Scholar 

  • Becker BS, Burakoff R. Differential effect of verapamil on LESP in normal subjects and those with achalasia. Abstract. Gastroenterology 18: 1107, 1981

    Google Scholar 

  • Becker BS, Burakoff R. The effectof verapamil on the lower esophageal sphincter pressure in normal subjects and in achalasia. American Journal of Gastroenterology 78: 773–775, 1983

    PubMed  CAS  Google Scholar 

  • Bennett JR, Hendrix TR. Diffuse esophageal spasm: a disorder with more than one cause. Gastroenterology 59: 273–279, 1970

    PubMed  CAS  Google Scholar 

  • Berger K, McCallum RW. Nifedipine in the treatment of achalasia. Annals of Internal Medicine 96: 61–62, 1982

    PubMed  CAS  Google Scholar 

  • Blackwell JN, Holt S, Heading RC. Effect of nifedipine on oesophageal motility and gastric emptying. Digestion 21: 50–56, 1981

    Article  PubMed  CAS  Google Scholar 

  • Bortolotti M, Labo G. Clinical and manometric effects of nifedipine in patients with esophageal achalasia. Gastroenterology 80: 39–44, 1981

    PubMed  CAS  Google Scholar 

  • Braunwald E, Mechanism of action of calcium-channel-blocking agents. New England Journal of Medicine 307: 1618–1627, 1982

    Article  PubMed  CAS  Google Scholar 

  • Cargill G, Theodore C, Paolaggi JA. Nifedipine for relief of esophageal chest pain? New England Journal of Medicine 307: 187, 1982

    PubMed  CAS  Google Scholar 

  • Castell DO. Chest pain of possible esophageal origin. Contemporary Internal Medicine 7: 71–83, 1990

    Google Scholar 

  • Cohen S. Motor disorders of the esophagus. New England Journal of Medicine 301: 184–192, 1979

    Article  PubMed  CAS  Google Scholar 

  • Cohen S, Green F. The mechanics of esophageal muscle contraction; evidence of an inotropic effect of gastrin. Journal of Clinical Investigation 52: 2029–2040, 1973

    Article  PubMed  CAS  Google Scholar 

  • Danielides IC, Mellow MH. Effect of acute hypercalcemia on human esophageal motility. Gastroenterology 75: 1115–1119, 1978

    PubMed  CAS  Google Scholar 

  • Davies HA, Lewis M, Rhodes J, Henderson A. Nifedipine for relief of esophageal chest pain: New England Journal of Medicine 307: 1274, 1982

    PubMed  CAS  Google Scholar 

  • de Carle DJ, Christensen J, Szabo AC, et al. Calcium dependence of neuromuscular events in esophageal smooth muscle of the opossum. American Journal of Physiology 232: E547–E552, 1977

    PubMed  Google Scholar 

  • DiMarino Jr AJ, Cohen S. Characteristics of lower esophageal sphincter function in symptomatic diffuse esophageal spasm. Gastroenterology 66: 1–6, 1974

    PubMed  Google Scholar 

  • Drenth JPH, Bos LP, Engels LGJ. Efficacy of diltiazem in the treatment of diffuse oesophageal spasm. Alimentary Pharmacololgy and Therapeutics 4: 411–414, 1990

    Article  CAS  Google Scholar 

  • Fleckenstein A. Specific inhibitors and promoters of calcium action in the excitation-contraction coupling of heart muscle and their role in the production and prevention of myocardial lesions. In Harris P, Opie L (Eds) Calcium and the heart, Proceedings of the European Section of the Internation Study Group of Research in Cardiac Metabolism, pp. 135–188, Academic Press, London, 1970

    Google Scholar 

  • Gelfond M, Rozen P, Gilat T. Isosorbide dinitrate and nifedipine treatment of achalasia: a clinical, manometric and radio-nuclide evaluation. Gastroenterology 83: 963–969, 1982

    PubMed  CAS  Google Scholar 

  • Henderson RD. Diffuse esophageal spasm. Surgical Clinics of North America 63: 951–962, 1983

    PubMed  CAS  Google Scholar 

  • Hongo M, Traube M, McAllister Jr RG, McCallum RW. Effects of nifedipine on esophageal motor function in humans: correlation with plasma nifedipine concentration. Gastroenterology 86: 8–12, 1984a

    PubMed  CAS  Google Scholar 

  • Hongo M, Traube M, McCallum RW. Comparison of effects of nifedipine, propantheline bromide, and the combination on esophageal motor function in normal volunteers. Digestive Diseases and Sciences 29: 300–304, 1984b

    Article  PubMed  CAS  Google Scholar 

  • Katz AM, Hager WD, Messineo FC, Pappano AJ. Cellular actions and pharmacology of the calcium channel blocking drugs. American Journal of Medicine 79 (Suppl. 4A): 2–10, 1985

    Article  CAS  Google Scholar 

  • Nasrallah SM. Nifedipine in the treatment of diffuse oesophageal spasm. Lancet 2: 1285, 1982

    Article  PubMed  CAS  Google Scholar 

  • Nasrallah SM, Tommaso CL, Singleton RT, Backhaus EA. Primary esophageal motor disorders: clinical response to nifedipine. Southern Medical Journal 78: 312–315, 1985

    Article  PubMed  CAS  Google Scholar 

  • Orr WC, Allen ML, Mellow M, et al. Differential effects of calcium channel blocking and anticholinergic agents on esophageal functioning. Abstract. Gastroenterology 86: 1202, 1984

    Google Scholar 

  • Pulido GJ, Patel PH, Hunter WC, Douglas JE, Thomas E. Esophageal contribution to chest pain in patients with coronary artery disease. Chest 98: 806–810, 1990

    Article  Google Scholar 

  • Reynolds JC, Parkman HP. Achalasia. Gastroenterololgy Clinics of North America 18: 223–255, 1989

    CAS  Google Scholar 

  • Richter JE, Castell DO. Diffuse esophageal spasm: a reappraisal. Annals of Internal Medicine 100: 242–245, 1984

    PubMed  CAS  Google Scholar 

  • Richter JE, Dalton CB, Buice RG, Castell DO. Nifedipine: a potent inhibitor of contractions in the body of the human esophagus (studies in healthy volunteers and patients with the nutcracker esophagus). Gastroenterology 89: 549–549, 1985

    PubMed  CAS  Google Scholar 

  • Richter JE, Sinar DR, Cordova CM, Castell DO. Verapamil-a potent inhibitor of esophageal contractions in the baboon. Gastroenterology 82: 882–886, 1982

    PubMed  CAS  Google Scholar 

  • Richter JE, Spurling TJ, Cordova CM, Castell DO. Effects of oral calcium blocker, diltiazem, on esophageal contractions (studies in volunteers and patients with nutcracker esophagus). Digestive Diseases and Sciences 29: 649–656, 1984

    Article  PubMed  CAS  Google Scholar 

  • Robertson CS, Hardy JG, Atkinson M. Quantitative assessment of the response to therapy in achalasia of the cardia. Gut 30: 768–773, 1989

    Article  PubMed  CAS  Google Scholar 

  • Silverstein BD, Kramer CM, Pope II CE. Treatment of esophageal motor disorders with a calcium-blocker diltiazem. Abstract. Gastroenterology 82: 1181, 1982

    Google Scholar 

  • Singh BN, Baky S, Nademanee K. Second-generation calcium antagonists: search for greater selectivity and versatility. American Journal of Cardiology 55: 214B-221B, 1985

    Article  Google Scholar 

  • Thomas E, Lebow RA, Gubler RJ, Bryant LR. Nifedipine for the poor-risk elderly patient with achalasia: Objective response demonstrated by solid meal study. Southern Medical Journal 77: 394–396, 1984

    Article  PubMed  CAS  Google Scholar 

  • Thomas E Salazar Y. Use of drug therapy for achalasia in the older patient. Geriatric Medicine Today 4: 42–44, 1985

    CAS  Google Scholar 

  • Thomas E, Witt P, Willis M, Morse J. Nifedipine therapy for the diffuse esophageal spasm. Southern Medical Journal 79: 847–849, 1986

    Article  PubMed  CAS  Google Scholar 

  • Tracy TS, Black CD. Calcium modulators: Future agents, future uses. Drug Intelligence and Clinical Pharmacy 21: 575–583, 1987

    PubMed  CAS  Google Scholar 

  • Traube M, Dubovik S, Lange RC, McCallum RW. The role of nifedipine therapy in achalasia: results of a randomized, double-blind, placebo-controlled study. American Journal of Gastroenterology 84: 1259–1262, 1989

    PubMed  CAS  Google Scholar 

  • Traube M, Hongo M, Magyar L, McCallum RW. Effects of nifedipine in achalasia and in patients with high-amplitude peristaltic esophageal contractions. Journal of the American Medical Association 252: 1733–1736, 1984

    Article  PubMed  CAS  Google Scholar 

  • Traube M, McCallum RW. Calcium-channel blockers and the gastrointestinal tract. American Journal of Gastroenterology 79: 892–896, 1984

    PubMed  CAS  Google Scholar 

  • Traube M, McCallum RW. Primary oesophageal motility disorders: current therapeutic concepts. Drugs 30: 66–77, 1985

    Article  PubMed  CAS  Google Scholar 

  • Triadafilopoulos G, Aaronson M, Sackel S, Burakoff R. Medical treatment of esophageal achalasia. Double-blind crossover study with oral nifedipine, verapamil, and placebo. Digestive Diseases and Sciences 36: 260–267, 1991

    Article  PubMed  CAS  Google Scholar 

  • Vantrappen G, Hellemans J. Achalasia. In Vantrappen G, Helle-mans J (Eds). Diseases of the oesophagus, pp 287–354, Springer-Verlag, Berlin, 1975

    Google Scholar 

  • Vantrappen G, Hellemans J. Treatment of achalasia and related-motor disorders. Gastroenterology 79: 144–154, 1980

    PubMed  CAS  Google Scholar 

  • Weiser HF, Lepsien G, Golenhofen K, et al. Clinical and experimental studies on the effect of nifedipine on smooth muscle of the oesophagus and LES. In Duthie HL (Ed.) Gastrointestinal motility in health and disease, pp. 565–572, MTP Press Limited, Lancaster, 1978

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, Department of Internal Medicine James H. Quillen College of Medicine, East Tennessee State University, Johnson City, Tennessee, USA

    Thomas P. Short &  Eapen Thomas

Authors
  1. Thomas P. Short
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eapen Thomas
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Short, T.P., Thomas, E. An Overview of the Role of Calcium Antagonists in the Treatment of Achalasia and Diffuse Oesophageal Spasm. Drugs 43, 177–184 (1992). https://doi.org/10.2165/00003495-199243020-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199243020-00004

Keywords

Search

Navigation